Back to all Programs

Register here

Related Materials

Past event

International Workshop on HBV Cure 2020

Viral Hepatitis and Liver Disease

Potential of new combinations to achieve functional cure for Chronic Hepatitis B - Fabien Zoulim, MD, PhD

Viral Hepatitis and Liver Disease

Rationale for including immune tolerant and low viral load patients in new drug trials placeholder - Henry Lik Yeun Chan

Viral Hepatitis and Liver Disease

How to interpret flares in HBV trials with novel agents - Pietro Lampertico, MD, PhD

Viral Hepatitis and Liver Disease

Toxicity in new and established HBV compounds - Jordan Feld, MD, MPH

Viral Hepatitis and Liver Disease

Safety Monitoring for Investigational HBV Drugs and Discontinuation of HBV Therapy - Poonam Mishra MD, MPH, FAASLD

Viral Hepatitis and Liver Disease

Update on Hepatitis Delta Therapy - Robert Gish MD, FAASLD, AGAF, FAST

Viral Hepatitis and Liver Disease

Update on New Antiviral Targets Core Capsid Inhibitors (CpAMs) - Kosh Agarwal BMedSci (Hons) MD FRCP

Viral Hepatitis and Liver Disease

Update on New Antiviral Targets –non –Capsid Inhibitors - Man-Fung Yuen MBBS, MD, PhD, DSc

Viral Hepatitis and Liver Disease

Update on New Immuno Modulators - Adam Gehring PhD

Viral Hepatitis and Liver Disease

Update on Novel Combination Strategies - Marion Peters MD